Anup Kasi, MD: [00:00:00] So this is an investigative initiated trial called the EPIC trial. Where we’re investigating n fotamibidotin, which is an antibody drug conjugate as a single arm, non randomized. Phase two study a single institution study at our site at University of Kansas in patients with advanced pancreatic cancer in the second … Continue reading EPIC Phase 2 Results: Enfortumab Vedotin in Advanced Pancreatic Cancer